Literature DB >> 2227116

Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.

M F Saad1, W C Knowler, D J Pettitt, R G Nelson, D M Mott, P H Bennett.   

Abstract

The relationships among blood pressure, obesity, glucose tolerance, and serum insulin concentration were studied in 2873 Pima Indians aged 18-92 yr (mean 37 yr). Age- and sex-adjusted to the Pima population, the prevalence of hypertension (systolic blood pressure greater than or equal to 160 mmHg, diastolic blood pressure greater than or equal to 95 mmHg, or receiving drug treatment) was 7.1% for subjects with normal glucose tolerance compared with 13.0% for subjects with impaired glucose tolerance (IGT) and 19.8% for those with non-insulin-dependent diabetes mellitus (NIDDM) (P less than 0.001). The prevalence ratio of hypertension was 1.8 (95% confidence interval [CI] 1.2-2.5) for IGT and 2.6 (95% CI 2.0-3.2) for NIDDM compared with normal glucose tolerance, controlled for age, sex, and body mass index (BMI). In logistic regression analysis, hypertension was positively related to age, male sex, BMI, glucose tolerance, and fasting but not 2-h postload serum insulin concentration. Among subjects not taking antihypertensive drugs, however, neither fasting nor 2-h postload serum insulin was significantly related to hypertension. Furthermore, in 2033 subjects receiving neither antihypertensive nor antidiabetic drugs, blood pressure was not significantly correlated to fasting insulin concentration, and 2-h postload serum insulin was negatively correlated with diastolic blood pressure. In conclusion, insulin is not significantly related to blood pressure in Pima Indians not receiving antihypertensive drugs. Higher insulin concentrations in drug-treated hypertensive patients might result from the treatment rather than contribute to the pathogenesis of hypertension. Thus, these data do not support a major role for insulin in determining the occurrence of hypertension or regulation of blood pressure in Pima Indians.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227116

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  Obesity and hypertension.

Authors:  E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 2.  The epidemiology of atherosclerosis and its risk factors among Native Americans.

Authors:  James M Galloway
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

3.  Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.

Authors:  P T Sawicki; L Heinemann; A Starke; M Berger
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

4.  Does impaired glucose tolerance predict hypertension? A prospective analysis.

Authors:  O Vaccaro; G Imperatore; V Iovino; C Iovine; A A Rivellese; G Riccardi
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

5.  Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.

Authors: 
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

6.  Hypertension in Pima Indians: prevalence and predictors.

Authors:  M P de Courten; D J Pettitt; W C Knowler
Journal:  Public Health Rep       Date:  1996       Impact factor: 2.792

7.  Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure.

Authors:  Reiner Jumpertz; Ana Guijarro; Richard E Pratley; Daniele Piomelli; Jonathan Krakoff
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

8.  Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss.

Authors:  Harvey J Sugerman; Luke G Wolfe; Domenic A Sica; John N Clore
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

9.  Plasma glucose and insulin responses to oral glucose loading in nonobese Nigerian subjects with essential hypertension.

Authors:  A O Akanji; A C Ojule; S Kadiri; B O Osotimehin
Journal:  J Natl Med Assoc       Date:  1993-04       Impact factor: 1.798

Review 10.  Pima Indian Contributions to Our Understanding of Diabetic Kidney Disease.

Authors:  Robert G Nelson; William C Knowler; Matthias Kretzler; Kevin V Lemley; Helen C Looker; Michael Mauer; William E Mitch; Behzad Najafian; Peter H Bennett
Journal:  Diabetes       Date:  2021-07-20       Impact factor: 9.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.